ADV.DEADV.DEXETRA
Loading
Year-over-year research & development expense growth
Percentile
P36
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q2 2025 | -0.43% |
| Q1 2025 | -25.61% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | -29.35% |
| Q1 2024 | 138.36% |
| Q4 2023 | 0.00% |
| Q3 2023 | -46.32% |
| Q2 2023 | 4.96% |
| Q1 2023 | 3.33% |
| Q4 2022 | 8.75% |
| Q3 2022 | 2.08% |
| Q2 2022 | 15.62% |
| Q1 2022 | 7.85% |
| Q4 2021 | -0.24% |
| Q3 2021 | -3.28% |
| Q2 2021 | -1.40% |
| Q1 2021 | 2.59% |
| Q4 2020 | 6.01% |
| Q3 2020 | -0.14% |
| Q2 2020 | -6.83% |
| Q1 2020 | -0.04% |
| Q4 2019 | 2.59% |
| Q3 2019 | 5.03% |
| Q2 2019 | -2.67% |
| Q1 2019 | 4.40% |
| Q4 2018 | -7.93% |
| Q3 2018 | 3.43% |
| Q2 2018 | -9.88% |
| Q1 2018 | 27.57% |
| Q4 2017 | -19.55% |
| Q3 2017 | 27.85% |
| Q2 2017 | -5.62% |
| Q1 2017 | 31.51% |
| Q4 2016 | -6.76% |
| Q3 2016 | -20.41% |
| Q2 2016 | 1.55% |
| Q1 2016 | 27.14% |
| Q4 2015 | 8.65% |
| Q3 2015 | 13.06% |